Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Aaron D Berger , MD

Urology • Chicago Ridge, IL

Active NPI 1720122005 Individual Practitioner Male Practitioner Accepts Medicare assignment Telehealth (some services)
Practice location in NPPES

10400 Southwest Hwy
Chicago Ridge, IL 604151427

Call 7088888287 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

10400 Southwest Hwy

Chicago Ridge, IL 604151427

Telephone 7088888287
Organization at the Same NPPES Address or Phone
Uropartners, Llc Facility NPI 1467471540

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 1 group name: Uropartners Llc. See the list

Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File

Medical School

University Of California, Geffen School Of Medicine

Graduation Year

2001

Medicare patients

1,148 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $1,172,110 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $916,148 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

8,475 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$19,859,408 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $176,898.74 across 362 records.

By nature of payment (3 largest of 6)

  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $117,162.50 across 39 records.
  • Consulting Fee: $30,935.75 across 13 records.
  • Travel and Lodging: $16,938.27 across 61 records.

Reporting-company totals (3 largest of 30)

  • Janssen Pharmaceuticals, Inc: $58,541.86 across 99 records.
  • Ferring Pharmaceuticals Inc.: $38,925.82 across 42 records.
  • Bayer Healthcare Pharmaceuticals Inc.: $19,154.51 across 26 records.

Research and ownership records are not included in these totals; they are in the table below.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

25 years (graduated 2001)

CMS Doctors and Clinicians data list 2001 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File.

NPI first issued

2007

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

Telehealth (some services)

Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.

What this does not show: Telehealth (some services)

It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Berger has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Berger as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Chicago Ridge and Illinois

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 95% of clinicians listed under Urology in Illinois (2024, 313 clinicians with data). Median for this group: 1,869. Middle half: 703 to 4,858.

Too few clinicians listed under Urology in Chicago Ridge have Medicare Part B data for 2024 to compare.

Medicare-allowed amount

A higher Medicare-allowed amount than 95% of clinicians listed under Urology in Illinois (2024, 313 clinicians with data). Median for this group: $150,002. Middle half: $69,734 to $268,150.

Too few clinicians listed under Urology in Chicago Ridge have Medicare Part B data for 2024 to compare.

Paid by Medicare

A higher Medicare payment amount than 95% of clinicians listed under Urology in Illinois (2024, 313 clinicians with data). Median for this group: $113,671. Middle half: $51,216 to $199,881.

Too few clinicians listed under Urology in Chicago Ridge have Medicare Part B data for 2024 to compare.

Medicare Part D prescriptions

More Part D prescriptions than 95% of clinicians listed under Urology in Illinois (2024, 381 clinicians with data). Median for this group: 813. Middle half: 123 to 1,932.

Too few clinicians listed under Urology in Chicago Ridge have Medicare Part D data for 2024 to compare.

Part D drug cost

A higher Part D drug cost than 95% of clinicians listed under Urology in Illinois (2024, 381 clinicians with data). Median for this group: $79,867. Middle half: $8,053 to $301,934.

Too few clinicians listed under Urology in Chicago Ridge have Medicare Part D data for 2024 to compare.

7 active clinicians are listed under Urology with a practice address in Chicago Ridge, IL (629 in Illinois).

Addresses are self-reported to NPPES and may be out of date.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 364 records totaling $195,898.74.

Manufacturer Payment Nature Product Type Amount ($)
Dendreon Pharmaceuticals LLC
General
Cash or cash equivalent
PROVENGE Research $16,500.00
Bayer Healthcare Pharmaceuticals Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
Nubeqa General $6,762.00
ACCORD HEALTHCARE, INC.
Consulting Fee
Cash or cash equivalent
Camcevi General $6,458.00
Bayer Healthcare Pharmaceuticals Inc.
Consulting Fee
Cash or cash equivalent
Nubeqa General $5,232.00
Ferring Pharmaceuticals Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
ADSTILADRIN General $4,550.00
Ferring Pharmaceuticals Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
ADSTILADRIN General $4,550.00
Astellas Pharma US Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
Xtandi General $4,550.00
Ferring Pharmaceuticals Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
ADSTILADRIN General $4,550.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $4,162.50
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $4,162.50
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $4,162.50
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $4,162.50
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $4,162.50
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $4,162.50
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $4,162.50
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $4,162.50
Astellas Pharma US Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
Xtandi General $3,900.00
Ferring Pharmaceuticals Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
ADSTILADRIN General $3,850.00
Ferring Pharmaceuticals Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
ADSTILADRIN General $3,850.00
Ferring Pharmaceuticals Inc.
Consulting Fee
Cash or cash equivalent
ADSTILADRIN General $3,850.00
Pfizer Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
XTANDI General $3,750.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $3,607.50
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $3,607.50
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $3,607.50
Sumitomo Pharma America, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
ORGOVYX General $3,575.00

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
J0897 Injection, denosumab, 1 mg
8,820 44 $60.00 $25.46
J1952 Leuprolide injectable, camcevi, 1 mg
5,376 97 $189.38 $56.24
J0585 Injection, onabotulinumtoxina, 1 unit
3,200 13 $24.00 $6.25
J9030 Bcg live intravesical instillation, 1 mg
1,250 12 $10.00 $2.84
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
1,199 727 $246.89 $130.66
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
1,139 755 $50.00 $16.64
81003 Automated urinalysis test
785 539 $20.00 $2.17
J0696 Injection, ceftriaxone sodium, per 250 mg
432 104 $39.31 $0.45
51798 Ultrasound measurement of bladder capacity after voiding
417 352 $100.00 $11.49
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
362 76 $128.53 $64.65
36415 Insertion of needle into vein for collection of blood sample
332 242 $20.01 $8.51
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
198 183 $163.00 $93.35
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
156 110 $160.00 $35.63
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
154 59 $154.00 $49.50
96372 Injection of drug or substance under skin or into muscle
133 77 $90.00 $14.60
52000 Diagnostic exam of bladder and urethra using an endoscope
105 96 $930.00 $245.89
A4648 Tissue marker, implantable, any type, each
95 33 $800.00 $128.98
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
90 14 $1533.33 $178.10
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
88 88 $302.00 $173.76
55874 Injection of biodegradable material next to prostate
85 85 $9000.00 $2805.88
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes
65 62 $190.00 $87.31
76872 Ultrasound scan of pelvic region through rectum
56 55 $590.00 $139.48
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
48 46 $260.00 $135.92
51702 Simple insertion of temporary bladder tube
43 30 $340.00 $62.01
55876 Placement of device in prostate for radiation therapy
33 33 $660.00 $85.87

(top 25 shown)

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Tamsulosin Hcl Tamsulosin Hcl 941 67,184 $12,366.39 326
Erleada Apalutamide 617 18,833 $8,789,858.28 92
Orgovyx Relugolix 495 14,796 $1,276,414.63 79
Xtandi Enzalutamide 481 14,383 $6,442,233.51 76
Oxybutynin Chloride Er Oxybutynin Chloride 352 21,307 $7,103.77 116
Finasteride Finasteride 275 21,326 $3,304.42 93
Solifenacin Succinate Solifenacin Succinate 246 14,229 $11,520.06 86
Abiraterone Acetate Abiraterone Acetate 200 6,000 $469,849.33 40
Nubeqa Darolutamide 199 5,892 $2,525,073.79 33
Prednisone Prednisone 179 5,709 $668.99 43
Alendronate Sodium Alendronate Sodium 137 11,523 $1,263.46 58
Myrbetriq Mirabegron 132 5,184 $78,780.88 45
Dutasteride Dutasteride 129 6,637 $3,725.66 36
Sildenafil Citrate Sildenafil Citrate 111 4,570 $1,444.04 34
Nitrofurantoin Nitrofurantoin Macrocrystal 100 3,354 $2,023.08 25
Oxybutynin Chloride Oxybutynin Chloride 98 7,755 $1,038.37 39
Gemtesa Vibegron 58 2,700 $43,581.77 14
Ciprofloxacin Hcl Ciprofloxacin Hcl 48 242 $225.42 45
Alfuzosin Hcl Er Alfuzosin Hcl 47 3,299 $1,342.56 21
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim 35 242 $104.05 31
Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst 35 189 $336.10 32
Silodosin Silodosin 35 2,070 $2,584.53 17
Dutasteride-Tamsulosin Dutasteride/Tamsulosin Hcl 29 2,310 $6,855.70 11
Trospium Chloride Trospium Chloride 28 1,635 $530.82 12
Bicalutamide Bicalutamide 25 1,710 $731.16 12

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Self-certified to NPPES: 2025-04-16
Urology Primary Specialty

NUCC Taxonomy Code: 208800000X

License # reported to NPPES IL 036120732

A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.

Urology

NUCC Taxonomy Code: 208800000X

License # reported to NPPES CA A98717

A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Illinois Department of Financial and Professional Regulation.
Look Up on State Board Site

Additional State Medicaid & Healthcare Payer Identifiers

Medicaid ID
036120732 (IL)
Other Identifier Bcbs
02232706 (IL)

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - UROLOGY

Medicare Enrollment ID

I20080716000834

Enrollment State Jurisdiction

IL

PECOS Control ID

5597838029

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File

Uropartners Llc

1851 Silver Cross Blvd, New Lenox, IL 604519629

Phone: 8154094930

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

25 listed
Isabel Betancourt , FNP-BC

Nurse Practitioner - Family

NPI 1447707880

Family Nurse Practitioner (Board Certified)

Karen Brann , APN

Nurse Practitioner - Family

NPI 1043676448

Advanced Practice Nurse

NPI 1548284730

Doctor of Medicine (M.D.)

Dr. Brett Cox , MD

Radiology - Radiation Oncology

NPI 1811192099

Doctor of Medicine (M.D.)

NPI 1629008164

Doctor of Medicine (M.D.)

NPI 1831694694

Career & Practice History

NPI enumerated February 19, 2007.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1720122005
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: February 19, 2007
Last Update: April 16, 2025
Sole Proprietor: No

Other Urology Specialists in Chicago Ridge

Mailing Address

10400 Southwest Hwy

Chicago Ridge, IL 604151427

Phone: 7088888287

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.